Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Capsoil Foodtech is a biotechnology company that specializes in converting bioactive oils and lipophilic nutrients into water-soluble, self-emulsifying powders. Utilizing its proprietary Liposoll™ nanotechnology platform, the company enhances the bioavailability, stability, and absorption of ingredients such as Omega-3, fat-soluble vitamins (A, D, E, K), and cannabinoids. This technology enables the seamless integration of oil-based compounds into a wide range of formats, including functional foods, beverages, gummies, and coffee pods. Established by the Prodalim Group, Capsoil operates an R&D center in Israel and maintains production facilities in the United States to serve the global nutraceutical and cosmetic markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CapSoil.